Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax
Clinical trial NCT01570036 · COMPLETED
Trial details
- NCT number
- NCT01570036
- Sponsor
- George E. Peoples
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-21
- Primary completion
- 2018-09-28
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.